Europe Biomarker Technologies Market Growth Analysis 2028

Report Description

Europe biomarker technologies market is expected to observe impressive growth during the forecast period, 2024-2028. Widespread incidences of various diseases such as cancer, diabetes, cardiovascular and neurological disorders, among others coupled with the growing technological advancements are expected to bolster the growth of the Europe biomarker technologies market. According to the IDF Diabetes Atlas, in 2021, about 61 million adults aged from 20 to 79 years were living with diabetes in the Europe. Besides, Europe has the highest number of children and adolescents with type 1 diabetes, accounting for 295,000 in total. Biomarker technologies are reliable and cost-effective which are used for diagnosis, drug development, and formulation. They are widely used for the early diagnosis of several diseases and disorders. The other factors supporting the market’s growth are rising number of individuals who are suffering from cancer, robust growth of the geriatric population, increase in healthcare expenditure, escalating demand for early and effective diagnosis, rising awareness about the early detection of cancer for better treatment, increasing investments in R&Ds in order to develop technologically advanced products, growing clinical trials for biomarker, and rising involvement from private sector and government. Additionally, governments across various European nations are also promoting biomarker technologies by increasing funding for biomarker research. Thus, increasing R&D activities is further expected to propel the growth of Europe biomarker technologies market in coming years. Moreover, growing adoption of biomarker technologies in drug development and genome mapping programs and increasing preference for personalized medicines is acting as major growth driver for Europe biomarker technologies market.

Europe biomarker technologies market is segmented into test type, technology, product, indication, end user, application, and country. Based on indication, the market can be segmented into oncology, infectious diseases, autoimmune disorders, cardiovascular disorders and others. Among them, the cardiovascular disorders segment is expected to undergo fastest CAGR during the forecast period owing to rise in number of people suffering from cardiovascular diseases.

Based on application, Europe biomarker technologies market is segmented into clinical diagnostics, research and drug discovery & development. Among these, the drug discovery segment is expected to witness significant growth through 2028 as biomarker technologies are helpful in drug discovery particularly for cancer and cardiovascular diseases.

Major players operating in the Europe biomarker technologies market are F. Hoffmann-La Roche AG, Merck KGAA, Beckman Coulter, Inc., Qiagen N.V., Biomérieux SA, Bio-Rad Laboratories N.V., Siemens AG, Abbott Molecular Inc., Danaher Corporation, and Epigenomics AG. The companies are undergoing growth strategies such as mergers & acquisitions and product innovation.

Objective of the Study:

To analyze and estimate the market size of Europe biomarker technologies market from 2018 to 2021.
To estimate and forecast the market size of Europe biomarker technologies market from 2022 to 2028 and growth rate until 2028.
To classify and forecast Europe biomarker technologies market based on test type, technology, product, indication, end user, application, company, and country.
To identify dominant country or segment in the Europe biomarker technologies market.
To identify drivers and challenges for Europe biomarker technologies market.
To examine competitive developments such as expansions, mergers & acquisitions, etc., in Europe biomarker technologies market.
To identify and analyze the profile of leading players operating in Europe biomarker technologies market.
To identify key sustainable strategies adopted by market players in Europe biomarker technologies market.

Download Free Sample Report

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of biomarker technologies companies across Europe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies who could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across Europe.

TechSci Research calculated the market size of Europe biomarker technologies market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and end users for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

Biomarker technology companies, vendors, end users and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums, and alliances related to biomarker technologies
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as biomarker technology companies, vendors, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million and CAGR for 2018-2022 and 2023-2028
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	· Test Type · Technology · Product · Indication · End User · Application
Country scope	Italy; France; United Kingdom; Germany; Spain; Belgium; Netherlands
Key companies profiled	F. Hoffmann-La Roche AG, Merck KGAA, Beckman Coulter, Inc., Qiagen N.V., Biomérieux SA, Bio-Rad Laboratories N.V., Siemens AG, Abbott Molecular Inc., Danaher Corporation, and Epigenomics AG.
Customization scope	10% free report customization with purchase. Addition or alteration to country, & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Europe biomarker technologies market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Europe Biomarker Technologies Market, By Test Type:

Solid Biopsy
Liquid Biopsy

Europe Biomarker Technologies Market, By Technology:

Immunoassay
DDPCR
Next Generation Sequencing (NGS)
Mass Spectrometry
DHPLC
Others

Europe Biomarker Technologies Market, By Product:

Consumables
Instruments
Services
Software/Informatics

Europe Biomarker Technologies Market, By Indication:

Oncology
Infectious Diseases
Autoimmune Disorders
Cardiovascular Disorders
Others

Europe Biomarker Technologies Market, By End User:

Pharmaceutical Companies
Hospitals
CROs
Diagnostic Labs
Research Institutes

Europe Biomarker Technologies Market, By Application:

Clinical Diagnostics
Research
Drug Discovery & Development

Europe Biomarker Technologies Market, By Country:

Italy
France
United Kingdom
Germany
Spain
Belgium
Netherlands

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Europe biomarker technologies market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

Profit margin analysis in case of direct and indirect sales channel.

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

5.1. Ongoing Clinical Trials

5.2. Completed Clinical Trials

5.3. Terminated Clinical Trials

5.4. Breakdown of Pipeline, By Development Phase

5.5. Breakdown of Pipeline, By Status

5.6. Breakdown of Pipeline, By Study Type

5.7. Breakdown of Pipeline, By Country

5.8. Clinical Trials Heat Map

6. Europe Biomarker Technologies Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Test Type (Solid Biopsy, Liquid Biopsy)

6.2.2. By Technology (Immunoassay, DDPCR, Next Generation Sequencing (NGS), Mass Spectrometry, DHPLC, Others)

6.2.3. By Product (Consumables, Instruments, Services, Software/Informatics)

6.2.4. By Indication (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others)

6.2.5. By End User (Pharmaceutical Companies, Hospitals, CROs, Diagnostic Labs, Research Institutes)

6.2.6. By Application (Clinical Diagnostics, Research, Drug Discovery & Development)

6.2.7. By Company (2022)

6.2.8. By Country

6.3. Market Map

7. France Biomarker Technologies Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Test Type

7.2.2. By Technology

7.2.3. By Product

7.2.4. By Application

8. Germany Biomarker Technologies Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Test Type

8.2.2. By Technology

8.2.3. By Product

8.2.4. By Application

9. United Kingdom Biomarker Technologies Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Test Type

9.2.2. By Technology

9.2.3. By Product

9.2.4. By Application

10. Italy Biomarker Technologies Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Test Type

10.2.2. By Technology

10.2.3. By Product

10.2.4. By Application

11. Spain Biomarker Technologies Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Test Type

11.2.2. By Technology

11.2.3. By Product

11.2.4. By Application

12. Finland Biomarker Technologies Market Outlook

12.1. Market Size & Forecast

12.1.1. By Value

12.2. Market Share & Forecast

12.2.1. By Test Type

12.2.2. By Technology

12.2.3. By Product

12.2.4. By Application

13. Greece Biomarker Technologies Market Outlook

13.1. Market Size & Forecast

13.1.1. By Value

13.2. Market Share & Forecast

13.2.1. By Test Type

13.2.2. By Technology

13.2.3. By Product

13.2.4. By Application

14. Portugal Biomarker Technologies Market Outlook

14.1. Market Size & Forecast

14.1.1. By Value

14.2. Market Share & Forecast

14.2.1. By Test Type

14.2.2. By Technology

14.2.3. By Product

14.2.4. By Application

15. Bulgaria Biomarker Technologies Market Outlook

15.1. Market Size & Forecast

15.1.1. By Value

15.2. Market Share & Forecast

15.2.1. By Test Type

15.2.2. By Technology

15.2.3. By Product

15.2.4. By Application

16. Croatia Biomarker Technologies Market Outlook

16.1. Market Size & Forecast

16.1.1. By Value

16.2. Market Share & Forecast

16.2.1. By Test Type

16.2.2. By Technology

16.2.3. By Product

16.2.4. By Application

17. Market Dynamics

17.1. Drivers

17.2. Challenges

18. Market Trends & Developments

19. Competitive Landscape

19.1. Competition Outlook

19.2. Regional Players Profiled (Leading Companies)

19.2.1. F. Hoffmann-La Roche AG

19.2.2. Merck KGAA

19.2.3. Beckman Coulter, Inc.

19.2.4. Qiagen N.V.

19.2.5. Biomérieux SA

19.2.6. Bio-Rad Laboratories N.V.

19.2.7. Siemens AG

19.2.8. Abbott Molecular Inc.

19.2.9. Danaher Corporation

19.2.10. Epigenomics AG

20. Strategic Recommendations

(Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions

What are the primary drivers of the Europe Biomarker Technologies Market?

Increasing R&D activities, rise in prevalence of cardiovascular and neurological disorders and growing adoption of biomarker technologies in drug development and genome mapping programs are driving the Europe Biomarker Technologies Market.

What application is expected to dominate the Europe Biomarker Technologies Market in the forecast period?

Based on application, the Europe Biomarker Technologies Market is divided into clinical diagnostics, research, and drug discovery & development. The drug discovery & development segment is expected to hold the largest market share in the forecast period as the biomarker technologies are helpful to find drugs for life-threatening diseases.

What indication is expected to dominate the Europe Biomarker Technologies Market in the forecast period?

Based on indication, the Europe Biomarker Technologies Market is divided into oncology, infectious diseases, autoimmune disorders, cardiovascular disorders, and others. Cardiovascular segment is expected to hold the largest market share in the forecast period as the drugs to treat cancer can be find by using advanced technologies.

Who are the leading operating market players in the Europe Biomarker Technologies Market?

F. Hoffmann-La Roche AG, Merck KGAA, Beckman Coulter, Inc., Qiagen N.V., Biomérieux SA, Bio-Rad Laboratories N.V., Siemens AG, Abbott Molecular Inc., Danaher Corporation, and Epigenomics AG are the major market players operating in the Europe Biomarker Technologies Market.

Buy Now